English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Zynex
Patient Daily
| May 18, 2023
Zynex Announces Proposed $50 Million Offering of Convertible Senior Notes
Patient Daily
| May 18, 2023
Zynex Announces Proposed Secondary Public Offering of Common Stock
Patient Daily
| May 18, 2023
Zynex Announces Update Regarding Previously Announced Offerings
Patient Daily
| May 18, 2023
Zynex Prices Upsized $52.5 Million Convertible Senior Notes Offering
Patient Daily
| Apr 24, 2023
Zynex, Inc. to Announce First Quarter 2023 Financial Results
Trending
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 17, 2025
UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+
Pharmaceuticals
Patient Daily
| Apr 22, 2025
National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+
Pharmaceuticals
Patient Daily
| Apr 23, 2025
Empower Pharmacy CEO on pharmaceutical industry pricing disparities: 'Is it fair to charge one person in another country 10 times more?'
